A study for a 17 year old boy who takes Lamictal - from FDA reports


Summary

2,396 males aged 17 (±5) who take the same drug are studied. This is a personalized study for a 17 year old male patient who has Bipolar Ii Disorder. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Oct, 11, 2017

2,396 males aged 17 (±5) who take Lamictal are studied.


Number of reports submitted per year:

Lamictal for a 17-year old boy.

Information of the patient in this study:

  • Age: 17
  • Gender: male
  • Conditions: Bipolar Ii Disorder
  • Drugs taken:
    • Lamictal (lamotrigine)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Akathisia: 5 (0.21% of males aged 17 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • rashes
  • fever
  • erythema multiforme
  • itching
  • nausea and vomiting
  • convulsion
  • fatigue
  • alanine aminotransferase increased
  • blister
  • thrombocytopenia
1 - 6 months:
  • rashes
  • fever
  • convulsion
  • erythema multiforme
  • transaminases increased
  • nausea and vomiting
  • drug ineffective
  • thrombocytopenia
  • staphylococcal infection
  • appetite - decreased
6 - 12 months:
  • rashes
  • feeling abnormal
  • convulsion
  • blister
  • itching
  • hyponatremia
  • erythema multiforme
  • malaise
  • inappropriate antidiuretic hormone secretion
  • weight increased
1 - 2 years:
  • convulsion
  • weight decreased
  • postictal paralysis
  • cognitive disorder
  • rashes
  • memory loss
  • insomnia
  • speech disorder
  • atrophy
  • gait disturbance
2 - 5 years:
  • fatigue
  • thrombocytopenia
  • agranulocytosis
  • weakness
  • aplastic anemia
  • bleeding into the skin
  • febrile neutropenia
  • increased tendency to bruise
  • dizziness
  • temperature intolerance
5 - 10 years:
  • rashes
  • itching
10+ years:
  • suicide attempt
  • hypotension
not specified:
  • convulsion
  • rashes
  • drug ineffective
  • fever
  • erythema multiforme
  • aggression
  • nausea and vomiting
  • fatigue
  • agitation
  • dizziness

Top conditions involved for these people *:

  • Convulsion (138 people, 5.76%)
  • Depression (72 people, 3.01%)
  • Attention Deficit Hyperactivity Disorder (69 people, 2.88%)
  • Seizures (57 people, 2.38%)
  • Partial Seizures (39 people, 1.63%)

Top co-used drugs for these people *:

  • Keppra (195 people, 8.14%)
  • Depakote (121 people, 5.05%)
  • Seroquel (117 people, 4.88%)
  • Abilify (105 people, 4.38%)
  • Tegretol (86 people, 3.59%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

  • Akathisia (a movement disorder characterized by a feeling of inner restlessness) has been reported by people with depression, schizophrenia, bipolar disorder, stress and anxiety, major depression (latest reports from 8,336 Akathisia patients).

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Bipolar ii disorder, Lamictal, Akathisia

You may be interested in these reviews

More reviews for: Bipolar ii disorder, Lamictal, Akathisia